v3.26.3
Condensed Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Revenues    
Total revenues $ 10,264 $ 14,260
Cost of revenues (6,377) (7,665)
Gross profit 3,887 6,595
Operating expenses:    
Selling and marketing (4,815) (5,910)
General and administrative (7,794) (5,932)
Total operating expenses (12,609) (11,842)
Loss from operations (8,722) (5,247)
Other income (expense)    
Other expense, net (2,817) (3,858)
Interest income 3 11
Loss before income taxes (11,536) (9,094)
Income tax expenses (13) (88)
Net loss (11,549) (9,182)
Less: Net income attributable to non-controlling interests 0 174
Net loss attributable to Lichen International Limited (11,549) (9,356)
Comprehensive (loss) income:    
Net loss (11,549) (9,182)
Foreign currency translation adjustments 1,874 154
Comprehensive loss $ (9,675) $ (9,028)
Weighted average number of ordinary shares outstanding – diluted (in Shares) [1] 16,326,825 282,846
Weighted average number of ordinary shares outstanding – basic (in Shares) [1] 16,326,825 282,846
(Loss) Earnings per ordinary share – diluted (in Dollars per share) [1] $ (0.71) $ (32.46)
(Loss) Earnings per ordinary share – basic (in Dollars per share) [1] $ (0.71) $ (32.46)
Financial and taxation solution services    
Revenues    
Total revenues $ 8,053 $ 11,579
Education support services    
Revenues    
Total revenues 0 760
Software and maintenance services    
Revenues    
Total revenues 1,271 1,330
Pre-IPO advisory services    
Revenues    
Total revenues $ 940 $ 591
[1] On March 3, 2025, the Company consolidated (each a “Share”) its common shares on the basis of 200 pre-consolidation Shares for one (1) post-consolidation share, which was approved by the Board on February 10, 2025. Share amounts have been retrospectively restated to reflect the post-consolidation number of shares.